{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:30:05Z","timestamp":1794051005124,"version":"4.8.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T00:00:00Z","timestamp":1451260800000},"content-version":"vor","delay-in-days":4013,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2005]]},"DOI":"10.1111\/j.1469-0691.2005.01160.x","type":"journal-article","created":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T15:14:11Z","timestamp":1118416451000},"page":"1-16","source":"Crossref","is-referenced-by-count":50,"special_numbering":"S4","title":["Multidrug resistance in Gram-negative bacteria that produce extended-spectrum \u03b2-lactamases (ESBLs)"],"prefix":"10.1016","volume":"11","author":[{"given":"H.","family":"Giamarellou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2005.01160.x_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev.mi.45.100191.000345","article-title":"Serine \u03b2-lactamases and penicillin-binding proteins","volume":"45","author":"Ghuysen","year":"1991","journal-title":"Annu Rev Microbiol"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/208239a0","article-title":"Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae","volume":"208","author":"Datta","year":"1965","journal-title":"Nature"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/oxfordjournals.bmb.a071942","article-title":"\u03b2-Lactamases","volume":"40","author":"Medeiros","year":"1984","journal-title":"Br Med Bull"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2174\/1381612805666230112183734","article-title":"SHV-type \u03b2-lactamases","volume":"5","author":"Tzouvelekis","year":"1999","journal-title":"Curr Pharm Des"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF01641355","article-title":"Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens","volume":"11","author":"Knothe","year":"1983","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","article-title":"Extended-spectrum \u03b2-lactamases in the 21st century; characterization, epidemiology and detection of this important resistance threat","volume":"14","author":"Bradford","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1098\/rstb.1980.0049","article-title":"The structure of \u03b2-lactamases","volume":"289","author":"Ambler","year":"1980","journal-title":"Phil Trans R Soc Lond Biol"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib8","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/AAC.39.6.1211","article-title":"A functional classification scheme for \u03b2-lactamases and its correlation with molecular structure","volume":"39","author":"Bush","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1128\/AAC.40.2.342","article-title":"In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins","volume":"40","author":"Martinez-Martinez","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/infdis\/159.5.1005","article-title":"In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 \u03b2-lactamase","volume":"159","author":"Pangon","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib11","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1128\/AAC.35.9.1697","article-title":"More extended-spectrum \u03b2-lactamases","volume":"35","author":"Jacoby","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib12","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1128\/AAC.43.11.2671","article-title":"Diversity of TEM mutants in Proteus mirabilis","volume":"43","author":"Bonnet","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib13","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1128\/AAC.43.8.2069","article-title":"TEM-24 produced by four different species of Enterobacteriaceae, including Providencia rettgeri, in a single patient","volume":"43","author":"Marchandin","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1128\/AAC.39.2.458","article-title":"New extended spectrum TEM-type \u03b2-lactamases from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak","volume":"39","author":"Morosini","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib15","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1128\/AAC.39.5.1199","article-title":"New variant of TEM-10 \u03b2-lactamase gene produced by a clinical isolate of Proteus mirabilis","volume":"39","author":"Paltzkill","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib16","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1128\/AAC.44.9.2537-2539.2000","article-title":"TEM-72, a new extended-spectrum \u03b2-lactamase detected in Proteus mirabilis and Morganella morganii in Italy","volume":"44","author":"Perilli","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib17","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1128\/AAC.42.8.2125","article-title":"Molecular characterization of a TEM-21 \u03b2-lactamase in a clinical isolate of Morganella morganii","volume":"42","author":"Tessier","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib18","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/AAC.44.3.760-762.2000","article-title":"Capnocytophaga ochracea; characterization of a plasmid-encoded extended-spectrum TEM-17 \u03b2-lactamase in the phylum Flavobacter-Bacteroides","volume":"44","author":"Rosenau","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib19","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1128\/AAC.40.11.2488","article-title":"A TEM-derived extended-spectrum \u03b2-lactamase in Pseudomonas aeruginosa","volume":"40","author":"Mugnier","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.8.4.557","article-title":"\u03b2-Lactamases in laboratory and clinical resistance","volume":"8","author":"Linermore","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0769-2609(85)80093-4","article-title":"Distinction entre les structures primaires des \u03b2-lactamases TEM-1 et TEM-2","volume":"136A","author":"Barthelemy","year":"1985","journal-title":"Ann Inst Pasteur Microbiol"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib22","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1016\/S0021-9258(18)53748-0","article-title":"Role of Ser-238 and Lys-240 in the hydrolysis of 3rd-generation cephalosporins by SHV-type beta-lactamases probed by site-directed mutagenesis and 3-dimensional modeling","volume":"268","author":"Huletsky","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/jac\/26.5.635","article-title":"Prevalence of a transferable SHV-5 type \u03b2-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece","volume":"26","author":"Vatopoulos","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1469-0691.2002.00391.x","article-title":"Transferable plasmid mediating resistance to multiple antimicrobial agents in Klebsiella pneumoniae in Greece","volume":"8","author":"Galani","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0378-1097(97)00013-X","article-title":"Tazobactam is a potent inactivator of selected inhibitor-resistant class A \u03b2-lactamases","volume":"148","author":"Bonomo","year":"1997","journal-title":"FEMS Microbiol Lett"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/jac\/43.4.447","article-title":"Inhibitor-resistant TEM-\u03b2-lactamases; phenotypic, genetic and biochemical characteristics","volume":"43","author":"Chaibi","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib27","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1128\/JCM.35.10.2593-2597.1997","article-title":"Occurrence and detection of extended-spectrum \u03b2-lactamases in members of the family Enterobacteriaceae at a Veterans Medical Center; seek and you may find","volume":"35","author":"Coudron","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/jac\/38.2.183","article-title":"Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 \u03b2-lactamase produced by Proteus mirabilis strains","volume":"38","author":"Bret","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib29","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1128\/AAC.39.11.2580","article-title":"First characterization of inhibitor-resistant TEM (IRT) \u03b2-lactamases in Klebsiella pneumoniae strains","volume":"33","author":"Lemozy","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib30","first-page":"75","article-title":"Nucleotide sequences of the genes coding for the TEM-like \u03b2-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2)","volume":"120","author":"Balaaouaj","year":"1994","journal-title":"FEMS Microbiol Lett"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/AAC.39.2.427","article-title":"Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM \u03b2-lactamases from clinical isolates of Escherichia coli","volume":"39","author":"Henquell","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib32","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1128\/AAC.38.5.1085","article-title":"Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 \u03b2-lactamase conferring resistance to \u03b2-lactamase inhibitors","volume":"38","author":"Zhou","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib33","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1128\/AAC.41.6.1322","article-title":"A complex mutant of TEM-1 \u03b2-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate","volume":"41","author":"Sirot","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0924-8579(99)00165-X","article-title":"CTX-Mtype \u03b2-lactamases; an emerging group of extended-spectrum enzymes","volume":"14","author":"Tzouvelekis","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib35","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/AAC.42.4.827","article-title":"Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland; identification of a new CTX-M-3 cefotaxime-hydrolyzing \u03b2-lactamase that is closely related to the CTX-M-1\/MEN-1 enzyme","volume":"42","author":"Gniadkowski","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib36","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1128\/AAC.42.8.1980","article-title":"CTX-M-5, a novel cefotaxime-hydrolyzing \u03b2-lactamase from an outbreak of Salmonella typhimurium in Latvia","volume":"42","author":"Bradford","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib37","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0891-5520(05)70395-0","article-title":"Extended-spectrum \u03b2-lactamases and other enzymes providing resistance to oximino-\u03b2-lactams","volume":"11","author":"Jacoby","year":"1997","journal-title":"Infect Dis Clin N Am"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib38","series-title":"Abstracts of the 43rd Interscience Conference of Antimicrobial Agents and Chemotherapy, September 14\u201317 2003, Chicago, IL, USA","article-title":"Alarming emergence of E. coli clinical isolates harbouring a variety of newly acquired \u03b2-lactamases in Athens, Greece","author":"Galani","year":"2003"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib39","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1128\/AAC.43.6.1362","article-title":"OXA-17, a further extended-spectrum variant of OXA-10 \u03b2-lactamase, isolated from Pseudomonas aeruginosa","volume":"43","author":"Danel","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib40","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1128\/AAC.37.8.1637","article-title":"OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) \u03b2-lactamase from Pseudomonas aeruginosa","volume":"37","author":"Hall","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib41","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1128\/AAC.42.8.2074","article-title":"Molecular characterization of OXA-20, a novel class D \u03b2-lactamase and its integron from Pseudomonas aeruginosa","volume":"42","author":"Naas","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib42","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1128\/AAC.44.8.2201-2204.2000","article-title":"Biochemical-genetic characterization and distribution of OXA-22, a chromosomal and inducible class D \u03b2-lactamase from Ralstonia (Pseudomonas) pickettii","volume":"44","author":"Nordmann","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/AAC.45.2.583-588.2001","article-title":"Characterization of OXA-25, OXA-26, and OXA-27, molecular class D \u03b2-lactamases associated with carbapenem resistance in clinical isolates of. Acinetobacter baumannii","volume":"45","author":"Afazal-Shah","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib44","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.44.6.1556-1561.2000","article-title":"OXA-24, a novel class D \u03b2-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain","volume":"44","author":"Bou","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib45","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1128\/AAC.44.8.2034-2038.2000","article-title":"\u03b2-Lactamases in Shigella flexneri isolates from Hong Kong and Shanghai and a novel OXA-1-like \u03b2-lactamase, OXA-30","volume":"44","author":"Siu","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib46","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1128\/AAC.37.5.962","article-title":"Characterization of a novel extended-spectrum \u03b2-lactamase from Pseudomonas aeruginosa","volume":"37","author":"Nordman","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib47","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1128\/JCM.34.12.2942-2946.1996","article-title":"Characterization of multiple-antibiotic-resistant Salmonella typhimurium strains; molecular epidemiology of PER-1-producing isolates and evidence for nosocomial plasmid exchange by a clone","volume":"34","author":"Vahaboglu","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib48","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1099\/00222615-43-4-294","article-title":"Resistance to extended-spectrum cephalosporins, caused by PER-1 \u03b2-lactamase, in Salmonella typhimurium from Istanbul, Turkey","volume":"43","author":"Vahaboglu","year":"1995","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib49","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1128\/AAC.41.10.2265","article-title":"Widespread detection of PER-1-type extended-spectrum \u03b2-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey; a nationwide multicenter study","volume":"41","author":"Vahaboglu","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib50","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/AAC.40.3.616","article-title":"Characterization of \u03b2-lactamase gene blaPER-2, which encodes an extended-spectrum class A \u03b2-lactamase","volume":"40","author":"Bauernfeind","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib51","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1128\/JCM.32.3.691-696.1994","article-title":"Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum \u03b2-lactamases","volume":"32","author":"Katsanis","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib52","series-title":"Approved Standard M7-A5 and Informational Supplement M100-S10","article-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"National Committee for Clinical Laboratory Standards","year":"2000"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib53","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/clinids\/10.4.867","article-title":"Extended broad-spectrum \u03b2-lactamases conferring transferable resistance to newer \u03b2-lactam agents in Enterobacteriaceae: hospital surveillance and susceptibility patterns","volume":"10","author":"Jarlier","year":"1988","journal-title":"Rev Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib54","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1128\/JCM.38.11.4228-4232.2000","article-title":"Detection of extended-spectrum \u03b2-lactamases in Klebsiella with the Oxoid combination disk method","volume":"38","author":"Carter","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib55","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/jac\/45.6.881","article-title":"Detection of extended-spectrum \u03b2-lactamases in members of the family Enterobacteriaceae: comparison of the MAST DD test, the double disc and the Etest ESBL","volume":"45","author":"M'Zali","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib56","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1128\/AAC.36.9.1877","article-title":"Detection of extended-spectrum \u03b2-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests","volume":"36","author":"Thomson","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib57","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1128\/JCM.34.12.2997-3001.1996","article-title":"Detection of extended-spectrum \u03b2-lactamase-producing members of the family Enterobacteriaceae with the Vitek ESBL tests","volume":"34","author":"Sanders","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib58","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1128\/JCM.38.2.542-546.2000","article-title":"Detection of extended-spectrum \u03b2-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes","volume":"38","author":"Tzelepi","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib59","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/jac\/38.3.409","article-title":"Antibiotic resistance and production of extended-spectrum \u03b2-lactamases amongst Klebsiella spp from intensive care units in Europe","volume":"38","author":"Livermore","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib60","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1128\/AAC.41.3.563","article-title":"Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC \u03b2-lactamase, and the loss of an outer membrane protein","volume":"41","author":"Bradford","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib61","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jac\/42.4.535","article-title":"Emergence of clinical isolates with decreased susceptibility to ceftazidime and synergistic effect with co-amoxiclav due to SHV-1 hyperproduction","volume":"42","author":"Miro","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1574-6968.1992.tb05240.x","article-title":"Does high level production of SHV-type penicillinase confer resistance to ceftazidime in Enterobacteriaceae?","volume":"92","author":"Petit","year":"1992","journal-title":"FEMS Microbiol Lett"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib63","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/AAC.44.2.362-367.2000","article-title":"High-level expression of chromosomically encoded SHV-1 \u03b2-lactamase and an outer membrane protein charge confer resistance to ceftazidime and piperacillin\u2013tazobactam in a clinical isolate of Klebsiella pneumoniae","volume":"44","author":"Rice","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib64","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1128\/AAC.38.4.761","article-title":"Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of an extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing \u03b2-lactamase in a single isolate","volume":"38","author":"Bradford","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib65","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/517217","article-title":"Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis","volume":"28","author":"Paterson","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib66","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/jac\/37.1.203","article-title":"Treatment failure due to extended spectrum \u03b2-lactamase","volume":"37","author":"Karas","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib67","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1086\/319610","article-title":"New-\u03b2-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy","volume":"32","author":"Bush","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib68","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1128\/JCM.34.4.908-911.1996","article-title":"Detection of extended-spectrum \u03b2-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli","volume":"34","author":"Jacoby","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib69","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1097\/00006454-199703001-00005","article-title":"Comparative susceptibility of clinical isolates producing extended-spectrum beta-lactamases to ceftibuten: effect of a large inoculum","volume":"16","author":"Medeiros","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib70","series-title":"Infectious Diseases","first-page":"663","article-title":"Endocarditis","author":"Korzeniowski","year":"1998"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/16.1.1","article-title":"Animal models of pneumonia for evaluation of antimicrobial therapy","volume":"16","author":"Pennington","year":"1985","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib72","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1128\/AAC.45.12.3548-3554.2001","article-title":"Cefepime, piperacillin\u2013tazobactam, and the inoculum effect in tests with extended-spectrum \u03b2-lactamase-producing enterobacteriaceae","volume":"45","author":"Thomson","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib73","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/clinids\/23.4.779","article-title":"Antimicrobial resistance rates among Gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program","volume":"23","author":"Itokazu","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib74","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1086\/520193","article-title":"Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals. Project ICARE: Phase 2","volume":"29","author":"Fridkin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib75","unstructured":"Mathai D, Jones JN, Stilwell M, Pfaller MA. Three-year analysis of pathogen occurrence and antimicrobial resistance in 315 intensive care units within 71 participating medical centers (32 nations). Report from the SENTRY antimicrobial surveillance program (1997\u201399). Presented in part at the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 2000. Abstract Poster 1027."},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib76","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1053\/jhin.2001.0987","article-title":"Surveillance of antibiotic resistance in European ICUs","volume":"48","author":"Hanberger","year":"2001","journal-title":"J Hosp Infect"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib77","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1034\/j.1600-0463.2000.d01-50.x","article-title":"Comparison of screening methods for detection of extended-spectrum \u03b2-lactamases and their prevalence among Escherichia coli and Klebsiella species in Hong Kong","volume":"108","author":"Ho","year":"2000","journal-title":"APMIS"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib78","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1128\/JCM.37.6.1758-1763.1999","article-title":"Survey of extended-spectrum \u03b2-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea","volume":"37","author":"Pai","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib79","first-page":"53","article-title":"A preliminary survey of extended-spectrum \u03b2-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan","volume":"184","author":"Yagi","year":"2000","journal-title":"FEMS Microbiol Lett"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib80","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/AAC.44.6.1438-1442.2000","article-title":"Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum \u03b2-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan","volume":"44","author":"Yan","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib81","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jac\/38.1.127","article-title":"Survey of prevalence of extended-spectrum \u03b2-lactamases among enterobacteriaceae","volume":"38","author":"Chanal","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib82","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jac\/41.5.527","article-title":"Epidemiological typing of Klebsiella with extended-spectrum \u03b2-lactamases from European intensive care units","volume":"41","author":"Yuan","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib83","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jac\/45.5.611","article-title":"Survey of Klebsiella pneumoniae producing extended-spectrum \u03b2-lactamases at a Portuguese hospital: TEM-10 as the endemic enzyme","volume":"45","author":"Barroso","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib84","first-page":"2580","article-title":"Survey of the prevalence of extended-spectrum \u03b2-lactamases amongst Klebsiella spp from intensive care units at the Royal London hospital","volume":"33","author":"Liu","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib85","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/JCM.34.1.76-79.1996","article-title":"Outbreak of TEM-24 producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum \u03b2-lactamase to other members of the family enterobacteriaceae","volume":"34","author":"Neuwith","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib86","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/313719","article-title":"Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum \u03b2-lactamase production in Klebsiella pneumoniae isolates causing bacteremia","volume":"30","author":"Paterson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib87","series-title":"Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 15\u201318 1996, New Orleans, USA","article-title":"Risk factor assessment of neonates colonized or infected with an extended-spectrum \u03b2-lactamase (ESBL) producing Klebsiella oxytoca in a neonatal intensive care unit (NICU)","author":"Swanson","year":"1996"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib88","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/clinids\/22.3.430","article-title":"Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition","volume":"22","author":"Lucet","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib89","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0195-6701(91)90088-P","article-title":"A case\u2013control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) \u03b2-lactamase","volume":"18","author":"De Champs","year":"1991","journal-title":"J Hosp Infect"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib90","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/infdis\/174.3.529","article-title":"Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case\u2013control and molecular epidemiologic investigation","volume":"174","author":"Schiappa","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib91","series-title":"Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 28\u2013October 1 1997, Toronto, Ontario, Canada","article-title":"Klebsiella pneumoniae bacteremia: impact of extended spectrum \u03b2-lactamase (ESBL) produced in a global study of 216 patients","author":"Paterson","year":"1997"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib92","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1128\/AAC.42.1.53","article-title":"Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases","volume":"42","author":"Pena","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib93","series-title":"Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, October 4\u20137, 1994, Orlando, FL, USA","article-title":"Multiply drug resistant Klebsiella pneumoniae (MDRDP) strains: predictors of acquisition and mortality","author":"Hibberd","year":"1994"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib94","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/319757","article-title":"Extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes","volume":"32","author":"Lautenbach","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib95","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1128\/AAC.34.11.2193","article-title":"Outbreak of ceftazidime resistance caused by extended-spectrum \u03b2-lactamases at a Massachusetts chronic-care facility","volume":"34","author":"Rice","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib96","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-119-5-199309010-00001","article-title":"Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins","volume":"119","author":"Meyer","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib97","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1128\/AAC.36.9.1991","article-title":"Outbreak of ceftazidime resistance due to a novel extended-spectrum \u03b2-lactamase in isolates from cancer patients","volume":"36","author":"Naumovski","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib98","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/JCM.39.6.2206-2212.2001","article-title":"Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum \u03b2-lactamases; implications for the Clinical Microbiology Laboratory","volume":"39","author":"Paterson","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib99","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1086\/324742","article-title":"Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime","volume":"34","author":"Wong-Beringer","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib100","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1592\/phco.21.6.583.34537","article-title":"Therapeutic changes associated with extended-spectrum, beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae","volume":"21","author":"Wong-Beringer","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib101","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/514643","article-title":"Spread of extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae; are \u03b2-lactamase inhibitors of therapeutic value?","volume":"27","author":"Piroth","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib102","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1128\/JCM.34.2.358-363.1996","article-title":"Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and \u03b2-lactam\u2013\u03b2-lactamase inhibitor combinations by hyperproduction of SHV-5 \u03b2-lactamase","volume":"34","author":"French","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib103","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(94)90694-7","article-title":"Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam","volume":"344","author":"Go","year":"1994","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib104","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/514732","article-title":"Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"28","author":"Levin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib105","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1345\/aph.18426","article-title":"Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria","volume":"33","author":"Evans","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib106","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0195-6701(97)90088-8","article-title":"Epidemiological typing of extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae isolates responsible for five outbreaks in a University hospital","volume":"36","author":"Branger","year":"1997","journal-title":"J Hosp Infect"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib107","first-page":"1","article-title":"Guideline for hand hygiene in healthcare settings. Recommendations of the Health-care Infection Control Practice Advisory Committee and the HIPAC\/SHEA\/APIC\/IDSA. Hand Hygiene Task Force Center for Disease Control and Prevention","volume":"51","author":"Boyce","year":"2002","journal-title":"Morbidity Mortality Weekly Rep"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib108","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1126\/science.257.5073.1050","article-title":"Epidemiology of drug resistance: implications for a post antimicrobial era","volume":"257","author":"Cohen","year":"1992","journal-title":"Science"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib109","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1086\/375082","article-title":"Routine cycling of antimicrobial agents as an infection-control measure","volume":"36","author":"Fridkin","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/clinids\/23.1.118","article-title":"Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center","volume":"23","author":"Rice","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib111","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.280.14.1233","article-title":"Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella","volume":"280","author":"Rahal","year":"1998","journal-title":"J Am Med Assoc"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib112","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1086\/501787","article-title":"Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae","volume":"21","author":"Patterson","year":"2000","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib113","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1128\/JCM.39.5.1865-1870.2001","article-title":"Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum \u03b2-lactamase","volume":"39","author":"Luzzaro","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib114","series-title":"Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, September 22\u201325, 2000, Chicago, IL, USA","article-title":"Reduction of antibiotic consumption can reverse increasing resistance rates","author":"Antoniadou","year":"2000"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib115","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/00003246-200106000-00001","article-title":"Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit","volume":"29","author":"Raymond","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib116","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1128\/AAC.40.2.509","article-title":"Sequences of \u03b2-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other \u03b2-lactamases","volume":"40","author":"Bauernfeind","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib117","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1128\/AAC.44.7.1936-1942.2000","article-title":"A novel CTX-M \u03b2-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil","volume":"44","author":"Bonnet","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib118","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1128\/AAC.44.7.1970-1973.2000","article-title":"Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing \u03b2-lactamase (CTX-M-9) from Escherichia coli in Spain","volume":"44","author":"Sabate","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib119","first-page":"161","article-title":"Diversity of CTX-M \u03b2-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals","volume":"209","author":"Saladin","year":"2002","journal-title":"FEMS Microbiol Lett"},{"key":"10.1111\/j.1469-0691.2005.01160.x_bib120","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1128\/AAC.48.12.4829-4834.2004","article-title":"Molecular and kinetic comparison of the novel extended-spectrum beta-lactamases CTX-M-25 and CTX-M-26","volume":"48","author":"Munday","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15300379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15300379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T09:59:28Z","timestamp":1683107968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X15300379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":120,"alternative-id":["S1198743X15300379"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2005.01160.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2005]]}}}